Oragenics : Shareholder Meeting - Form 8-K

Item 5.08 Shareholder Director Nominations

The Board of Directors of the Company previously established July 15, 2024 as the date of the Company's 2023 Annual Meeting of Shareholders (the "2023 Annual Meeting"). The Board of Directors have determined it is in the best interest of the Company to reschedule the 2023 Annual Meeting to August 26, 2024. Because the date of the 2023 Annual Meeting has advanced by more than 30 days from the anniversary date of the Company's 2022 Annual Meeting of Shareholders (the "2022 Annual Meeting"), in accordance with Rule 14a−5(f) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company is informing shareholders of such change. The record date, time and location of the 2023 Annual Meeting will be as set forth in the Company's proxy statement for the 2023 Annual Meeting.

Because the date of the 2023 Annual Meeting has been changed by more than 30 days from the anniversary of the 2022 Annual Meeting of Shareholders, a new deadline has been set for submission of proposals by Shareholders intended to be included in the Company's 2023 proxy statement and form of proxy. Proposals to be included in the Company's proxy statement for the 2023 Annual Meeting in accordance with Rule 14a-8 under the Exchange Act, must be received by the Company on or before June 21, 2024, which the Company believes is a reasonable time before it expects to begin to print and send its proxy materials. Shareholders must deliver the proposals or nominations to the Company's principal executive offices at the following address: Oragenics, Inc., Attn: Corporate Secretary, 1990 Main Street, Suite 750, Sarasota, Florida 34236.